Evidence map›Paper›PMID 39654925›Full record

ArticleRSC advances2024

Biological and computational assessments of thiazole derivative-reinforced bile salt enriched nano carriers: a new gate in targeting SARS-CoV-2 spike protein.

Mohamed Y Zakaria, Ayman Abo Elmaaty, Rabeh El-Shesheny, Radwan Alnajjar, Omnia Kutkat, Sana Ben Moussa, Abdullah Yahya Abdullah Alzahrani, Sally A El-Zahaby, Ahmed A Al-Karmalawy

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in RSC advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mohamed Y ZakariaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, King Salman International University Ras Sudr 46612 South Sinai Egypt mohamed.yehia@ksiu.edu.eg.
Ayman Abo ElmaatyMedicinal Chemistry Department, Faculty of Pharmacy, Port Said University Port Said 42526 Egypt.
Rabeh El-SheshenyCenter of Scientific Excellence for Influenza Viruses, Water Pollution Research Department, Environmental Research Institute, National Research Centre Dokki-Giza 12622 Egypt.
Radwan AlnajjarCADD Unit, Faculty of Pharmacy, Libyan International Medical University Benghazi 16063 Libya.ORCID https://orcid.org/0000-0003-1869-9596
Omnia KutkatCenter of Scientific Excellence for Influenza Viruses, Water Pollution Research Department, Environmental Research Institute, National Research Centre Dokki-Giza 12622 Egypt.
Sana Ben MoussaDepartment of Chemistry, Faculty of Science and Arts, King Khalid University Mohail Assir Saudi Arabia.
Abdullah Yahya Abdullah AlzahraniDepartment of Chemistry, Faculty of Science and Arts, King Khalid University Mohail Assir Saudi Arabia.
Sally A El-ZahabyDepartment of Pharmaceutics and Industrial Pharmacy, PharmD Program, Egypt-Japan University of Science and Technology (E-Just) Alexandria Egypt.
Ahmed A Al-KarmalawyDepartment of Pharmaceutical Chemistry, College of Pharmacy, The University of Mashreq Baghdad 10023 Iraq.ORCID https://orcid.org/0000-0002-8173-6073

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is merit in investigating novel therapeutic molecules that hit vital targets during the viral infection cycle

Identifiers

PMID39654925
PMCPMC11627215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.